Search

Craig D. Ricci

Examiner (ID: 10445, Phone: (571)270-5864 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1611, 1628, 1614
Total Applications
1547
Issued Applications
760
Pending Applications
153
Abandoned Applications
681

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18739454 [patent_doc_number] => 20230348376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => VITAMIN D DERIVATIVE HAVING CYCLIC AMINE IN SIDE CHAIN [patent_app_type] => utility [patent_app_number] => 18/025762 [patent_app_country] => US [patent_app_date] => 2021-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025762 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025762
VITAMIN D DERIVATIVE HAVING CYCLIC AMINE IN SIDE CHAIN Sep 13, 2021 Pending
Array ( [id] => 18466986 [patent_doc_number] => 20230201266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => METHOD FOR TREATING ARTHRITIS BY USING STEM CELL PREPARATION AND METHOD FOR PREPARING STEM CELL PREPARATION [patent_app_type] => utility [patent_app_number] => 17/470487 [patent_app_country] => US [patent_app_date] => 2021-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6669 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470487 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/470487
Method for treating arthritis by using stem cell preparation and method for preparing stem cell preparation Sep 8, 2021 Issued
Array ( [id] => 17560909 [patent_doc_number] => 20220125058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => APPLICATION OF ATRACTYLODES LANCEOLATA ESSENTIAL OIL [patent_app_type] => utility [patent_app_number] => 17/447090 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1263 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17447090 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/447090
APPLICATION OF ATRACTYLODES LANCEOLATA ESSENTIAL OIL Sep 7, 2021 Abandoned
Array ( [id] => 17314388 [patent_doc_number] => 20210403436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES [patent_app_type] => utility [patent_app_number] => 17/467772 [patent_app_country] => US [patent_app_date] => 2021-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11196 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467772 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/467772
COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES Sep 6, 2021 Abandoned
Array ( [id] => 18647730 [patent_doc_number] => 20230293500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => AK3287 PREPARATION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/024343 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024343 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/024343
AK3287 PREPARATION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Sep 1, 2021 Pending
Array ( [id] => 20114995 [patent_doc_number] => 12364679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Esters for treatment of ocular inflammatory conditions [patent_app_type] => utility [patent_app_number] => 17/445520 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7105 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/445520
Esters for treatment of ocular inflammatory conditions Aug 19, 2021 Issued
Array ( [id] => 17655439 [patent_doc_number] => 20220175904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 17/408287 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12940 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17408287 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/408287
METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES Aug 19, 2021 Abandoned
Array ( [id] => 20114995 [patent_doc_number] => 12364679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Esters for treatment of ocular inflammatory conditions [patent_app_type] => utility [patent_app_number] => 17/445520 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7105 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/445520
Esters for treatment of ocular inflammatory conditions Aug 19, 2021 Issued
Array ( [id] => 20114995 [patent_doc_number] => 12364679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Esters for treatment of ocular inflammatory conditions [patent_app_type] => utility [patent_app_number] => 17/445520 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7105 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/445520
Esters for treatment of ocular inflammatory conditions Aug 19, 2021 Issued
Array ( [id] => 20114995 [patent_doc_number] => 12364679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Esters for treatment of ocular inflammatory conditions [patent_app_type] => utility [patent_app_number] => 17/445520 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7105 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/445520
Esters for treatment of ocular inflammatory conditions Aug 19, 2021 Issued
Array ( [id] => 17426871 [patent_doc_number] => 20220054579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS [patent_app_type] => utility [patent_app_number] => 17/404680 [patent_app_country] => US [patent_app_date] => 2021-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8184 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17404680 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/404680
Methods and compositions for treatment of lysosomal storage disorders Aug 16, 2021 Issued
Array ( [id] => 17412056 [patent_doc_number] => 20220046960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => BEVERAGE COMPOSITION AND PROCESS [patent_app_type] => utility [patent_app_number] => 17/398827 [patent_app_country] => US [patent_app_date] => 2021-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6103 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398827 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/398827
BEVERAGE COMPOSITION AND PROCESS Aug 9, 2021 Pending
Array ( [id] => 17368208 [patent_doc_number] => 20220023260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => Ready to Use Ketorolac Formulations [patent_app_type] => utility [patent_app_number] => 17/396890 [patent_app_country] => US [patent_app_date] => 2021-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7250 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396890 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/396890
Ready to Use Ketorolac Formulations Aug 8, 2021 Pending
Array ( [id] => 18597131 [patent_doc_number] => 20230271923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-LI) EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/040858 [patent_app_country] => US [patent_app_date] => 2021-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18194 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040858 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/040858
IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-LI) EXPRESSION Aug 5, 2021 Pending
Array ( [id] => 18075892 [patent_doc_number] => 20220401504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => USE OF MAGNOLIA FIGO EXTRACT IN THE MANUFACTURE OF COMPOUND FOR INHIBITING GROWTH OF LUNG CANCER CELLS [patent_app_type] => utility [patent_app_number] => 17/394047 [patent_app_country] => US [patent_app_date] => 2021-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3069 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17394047 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/394047
Use of Magnolia figo extract in the manufacture of compound for inhibiting growth of lung cancer cells Aug 3, 2021 Issued
Array ( [id] => 18674972 [patent_doc_number] => 20230312495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => NEW ISOBUTYRAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSITIVE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/041742 [patent_app_country] => US [patent_app_date] => 2021-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5162 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041742 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/041742
NEW ISOBUTYRAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSITIVE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS Aug 1, 2021 Pending
Array ( [id] => 18581522 [patent_doc_number] => 20230263774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => OPTIMIZED SURGERY PROTOCOL AND KITS [patent_app_type] => utility [patent_app_number] => 18/040959 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22441 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040959 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/040959
OPTIMIZED SURGERY PROTOCOL AND KITS Jul 29, 2021 Pending
Array ( [id] => 18657619 [patent_doc_number] => 20230303543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => NOVEL STIRIPENTOL DERIVATIVE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/018792 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14126 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018792 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/018792
Stiripentol derivative and use thereof Jul 29, 2021 Issued
Array ( [id] => 18656032 [patent_doc_number] => 20230301898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION [patent_app_type] => utility [patent_app_number] => 18/018663 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14879 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018663 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/018663
EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION Jul 29, 2021 Pending
Array ( [id] => 18902638 [patent_doc_number] => 20240018123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => COMPOUND FOR INHIBITING OR DISINTEGRATING ANDROGEN RECEPTOR, AND PHARMACEUTICAL USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/017997 [patent_app_country] => US [patent_app_date] => 2021-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43326 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017997 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/017997
COMPOUND FOR INHIBITING OR DISINTEGRATING ANDROGEN RECEPTOR, AND PHARMACEUTICAL USE THEREOF Jul 27, 2021 Pending
Menu